UBS Group’s Prothena PRTA Stock Holding History
Bought
Maintained
Sold
Other funds holding PRTA
UBS Group's PRTA Position: Q3 2026 in Review
UBS Group increased its Prothena (PRTA) stake by 13% in Q3 2026, buying an estimated $277K and bringing the position to 272,478 shares worth $2.28M. The position accounts for ﹤0.01% of the portfolio, ranked #4894.
UBS Group first reported a position in PRTA in Q4 2014 and has held it in 48 quarters since. The position peaked at $5.52M in Q3 2021. 182 funds tracked by Wall St. Rank hold PRTA as of Q3 2026.
- UBS Group held 272,478 shares of Prothena worth $2.28M as of Q3 2026.
- UBS Group bought 31,053 Prothena shares in Q3 2026, an estimated $277K.
- Prothena made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #4894 holding.
- UBS Group first reported a position in Prothena in Q4 2014 and has held it in 48 quarters since.
- UBS Group's Prothena position peaked at $5.52M in Q3 2021.
- 182 funds tracked by Wall St. Rank held Prothena as of Q3 2026.
Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.